- Report
- December 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- April 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
The Breath Biopsy market is a subset of the In Vitro Diagnostics (IVD) industry. It is focused on the development of breath-based tests for the diagnosis and monitoring of diseases. These tests are based on the analysis of volatile organic compounds (VOCs) in exhaled breath, which can provide information about the presence of certain diseases. Breath biopsy tests are non-invasive, cost-effective, and can provide rapid results.
The Breath Biopsy market is expected to grow in the coming years due to the increasing demand for non-invasive diagnostic tests. The development of new technologies and the increasing availability of breath biopsy tests are also expected to drive the market.
Some companies in the Breath Biopsy market include Owlstone Medical, BreathDX, Exhale Diagnostics, and Breath Biopsy Technologies. Show Less Read more